Benjamin Mou

Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial

Robert Olson, Lindsay Mathews, Mitchell Liu et al. · BMC Cancer · 2020 · 115 citations · Full text

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer

Robert Olson, Will Jiang, Mitchell Liu et al. · JAMA Oncology · 2022 · 61 citations · Full text

Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial

Sarah Baker, Will Jiang, Benjamin Mou et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 41 citations

Local Control, Progression-free Survival, Oncology +5

Long-term Clinical Outcomes and Safety Profile of SBRT for Centrally Located NSCLC

Andrea Arnett, Benjamin Mou, Dawn Owen et al. · Advances in Radiation Oncology · 2019 · 31 citations · Full text

Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial

Devin Schellenberg, Zsolt Gabos, Adele Duimering et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 30 citations